[{"Assets_0_Q2_USD":"12682126000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-31.12","EarningsPerShareBasic_2_Q2_USD":"-143.88","EarningsPerShareDiluted_1_Q2_USD":"-31.12","EarningsPerShareDiluted_2_Q2_USD":"-143.88","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"96513000.0","NetIncomeLoss_1_Q2_USD":"-927184000.0","NetIncomeLoss_2_Q2_USD":"-4296797000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q2_USD":"691099000.0","RevenuesConverted_2_Q2_USD":"1391161000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q2_USD":"8922597000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"29794000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"29863000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"29794000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"29863000.0","filed":"20220729","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"BIO-RAD LABORATORIES, INC.","period":"20220630","qtrs":"0","uom":"USD"}]